Live Breaking News & Updates on Ed Pershing

Stay updated with breaking news from Ed pershing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Provectus Biopharmaceuticals Announces Stockholder Approval to Undertake Reverse Split of Outstanding Equities and Reduce Number of Authorized Equities by Same Ratio

Provectus Biopharmaceuticals Announces Stockholder Approval to Undertake Reverse Split of Outstanding Equities and Reduce Number of Authorized Equities by Same Ratio
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Ed Pershing , National Institutes Of Health , Company Annual Meeting Of Stockholders , Exchange Commission , Company Board , Provectus Biopharmaceuticals Inc , Provectus Biopharmaceuticals Inc Heather Raines , Annual Meeting , World Health Organization , National Institutes , Inc Heather Raines , Financial Officerphone , Provectus Biopharmaceuticals ,

State of Tennessee Awards Funding for Public-Private Partnership to Study Animal Cancers and Dermatological Disorders using Provectus Medical Science Platform

State of Tennessee Awards Funding for Public-Private


State of Tennessee Awards Funding for Public-Private Partnership to Study Animal Cancers and Dermatological Disorders using Provectus’ Medical Science Platform
May 25, 2021 07:00 ET
| Source:
Provectus Biopharmaceuticals Inc.
Provectus Biopharmaceuticals Inc.
Knoxville, UNITED STATES
KNOXVILLE, TN, May 25, 2021 (GLOBE NEWSWIRE) Provectus (OTCQB: PVCT) today announced that the State of Tennessee, as part of its fiscal year 2021-2022 budget, has directed funding in the amount of $2.5 million to develop animal health drug products through partnerships with state universities that have agriculture and veterinary medicine programs and the Knoxville-headquartered biotechnology company.
This study will pursue oncology, hematology, and dermatology treatments for companion and production animals, furthering research in these areas and eventual drug development. The foundation of this study is the Company’s ....

United States , State Of Tennessee , Ed Pershing , Dominic Rodrigues , Heather Raines , John Jack Lacey , Company Annual Report On Form , National Institutes Of Health , Provectus Biopharmaceuticals Inc , Provectu Board , Tennessee General Assembly , Provectu Strategic Advisory Board , Board Vice Chair , National Institutes , Annual Report , Provectu Quarterly Report , ஒன்றுபட்டது மாநிலங்களில் , நிலை ஆஃப் டென்னசி , எட் தொடர்கிறது , ஆதிக்கம் செலுத்தும் ரோட்ரிகஸ் , ஹீத்தர் மழை , நிறுவனம் ஆண்டு அறிக்கை ஆன் வடிவம் , தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம் , டென்னசி ஜநரல் சட்டசபை , பலகை துணை நாற்காலி , தேசிய நிறுவனங்கள் ,